跳至主要内容
临床试验/JPRN-UMIN000018755
JPRN-UMIN000018755已完成未知

A clinical study for evaluating the efficacy of the highly-concentrated oxygen nanobubble water -immune function, fatigue, autonomic nervous function and skin function- - A clinical study for evaluating the efficacy of the highly-concentrated oxygen nanobubble water

Soiken Inc.0 个研究点目标入组 17 人开始时间: 2016年3月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
Soiken Inc.
入组人数
17

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 60years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Subject receiving a medical treatment for serious renal, hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 2) Subject having the chronic fatigue syndrome(CFS) , or subject deemed to have severe fatigue like idiopathic chronic fatigue by the investigator 3) Subject having a medical history of chest pain or syncope 4) Subject having an abnormality in the electrocardiogram 5)Subject having a subjective symptom of low back pain, arthralgia or lumber hernia, disease of lower limbs, palpitations 6)Subjects who take regularly medical supplies or quasi-drugs which having the efficacy on recovery of fatigue or nutrition disorder at physical fatigue 7) Subjects who take regularly the highly-concentrated oxygen water 8) Subject having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 9)Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 10)Female subjects who is pregnant or lactating, or intending to become pregnant during the study 11)Subject deemed unsuitable by the investigator

研究者

发起方
Soiken Inc.

相似试验